HSIC
Henry Schein, Inc. NASDAQ Listed Nov 3, 1995$70.47
Mkt Cap $8.1B
52w Low $61.95
31.2% of range
52w High $89.29
50d MA $76.10
200d MA $72.64
P/E (TTM)
22.5x
EV/EBITDA
12.7x
P/B
1.9x
Debt/Equity
1.1x
ROE
12.3%
P/FCF
16.1x
RSI (14)
—
ATR (14)
—
Beta
0.88
50d MA
$76.10
200d MA
$72.64
Avg Volume
1.3M
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
135 Duryea Road · Melville, NY 11747 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 1.20 | 1.32 | +10.0% | 74.37 | +1.0% | -2.6% | -5.2% | — | — | — | — |
| Feb 24, 2026 | TNS | 1.30 | 1.34 | +3.1% | 83.35 | -0.9% | -1.7% | -1.7% | -2.3% | -1.2% | -2.4% | — |
| Nov 4, 2025 | TNS | 1.27 | 1.38 | +8.7% | 71.61 | -0.2% | +0.6% | +0.6% | -2.2% | +0.4% | +1.9% | — |
| Aug 5, 2025 | TNS | 1.18 | 1.10 | -6.8% | 64.83 | -0.0% | +2.3% | +2.3% | +1.7% | +1.7% | +2.0% | — |
| May 5, 2025 | TNS | 1.11 | 1.15 | +3.6% | 66.58 | +0.6% | -0.5% | -0.5% | -0.0% | +3.5% | +3.1% | — |
| Feb 25, 2025 | TNS | 1.23 | 1.19 | -3.3% | 75.82 | +0.1% | -4.3% | -4.3% | -4.9% | -4.8% | -6.6% | — |
| Nov 5, 2024 | TNS | 1.16 | 1.22 | +5.2% | 68.99 | +2.9% | +1.5% | +1.5% | +0.6% | -1.4% | -1.0% | — |
| Aug 6, 2024 | TNS | 1.22 | 1.23 | +0.8% | 63.92 | +1.4% | +2.9% | +2.9% | +6.6% | +7.9% | +6.2% | — |
| May 7, 2024 | TNS | 1.02 | 1.10 | +7.8% | 71.20 | +0.5% | +2.2% | +2.2% | +3.1% | +3.0% | +2.7% | — |
| Feb 27, 2024 | TNS | 0.70 | 0.66 | -5.7% | 77.85 | +0.4% | -1.7% | -1.7% | -1.8% | -1.2% | -1.4% | — |
| Nov 13, 2023 | TNS | 1.32 | 1.32 | +0.0% | 67.50 | +0.8% | +2.1% | +2.1% | +0.1% | +1.9% | +1.9% | — |
| Aug 7, 2023 | TNS | 1.28 | 1.31 | +2.3% | 75.87 | -0.3% | +0.1% | +0.1% | +2.0% | +0.8% | +1.0% | — |
| May 9, 2023 | BMO | 1.24 | 1.21 | -2.4% | 74.83 | +0.6% | +1.9% | +1.9% | +2.8% | +2.1% | +4.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | Morgan Stanley | Maintains | Underweight → Underweight | — | $78.22 | $78.02 | -0.3% | -0.9% | -1.3% | -2.7% | -5.7% | -4.6% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $73.85 | $73.91 | +0.1% | +2.3% | +2.4% | +2.0% | +2.9% | +4.5% |
| Feb 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 25 | JP Morgan | Maintains | Overweight → Overweight | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 25 | Morgan Stanley | Maintains | Underweight → Underweight | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 25 | Mizuho | Maintains | Neutral → Neutral | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 25 | Barrington Research | Maintains | Outperform → Outperform | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 25 | Evercore ISI | Maintains | Outperform → Outperform | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 25 | UBS | Maintains | Neutral → Neutral | — | $83.35 | $82.58 | -0.9% | -1.7% | -2.3% | -1.2% | -2.4% | -3.8% |
| Feb 24 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $80.57 | $84.00 | +4.3% | +3.5% | +1.7% | +1.1% | +2.3% | +1.0% |
| Feb 23 | Baird | Upgrade | Neutral → Outperform | — | $79.57 | $81.60 | +2.6% | +1.3% | +4.8% | +2.9% | +2.4% | +3.5% |
| Jan 20 | Mizuho | Maintains | Neutral → Neutral | — | $79.98 | $79.69 | -0.4% | -2.8% | -1.3% | -1.9% | -3.5% | -3.0% |
| Nov 5 | Morgan Stanley | Maintains | Underweight → Underweight | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.2% | +0.4% | +1.9% | +2.2% |
| Nov 5 | Evercore ISI | Maintains | Outperform → Outperform | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.2% | +0.4% | +1.9% | +2.2% |
| Nov 5 | Barrington Research | Maintains | Outperform → Outperform | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.2% | +0.4% | +1.9% | +2.2% |
| Nov 5 | JP Morgan | Maintains | Overweight → Overweight | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.2% | +0.4% | +1.9% | +2.2% |
| Nov 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.2% | +0.4% | +1.9% | +2.2% |
| Oct 22 | Barrington Research | Maintains | Outperform → Outperform | — | $64.23 | $64.23 | +0.0% | -1.1% | -1.0% | -0.6% | -1.1% | -1.6% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $67.92 | $68.13 | +0.3% | +1.9% | -0.3% | -3.4% | -2.7% | -2.8% |
| Aug 26 | Evercore ISI | Upgrade | In Line → Outperform | — | $68.47 | $69.80 | +1.9% | +0.9% | +0.7% | +0.8% | +1.6% | -0.1% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $66.32 | $67.08 | +1.1% | -0.6% | -0.6% | -0.3% | +1.8% | +4.0% |
| Aug 6 | Barrington Research | Maintains | Outperform → Outperform | — | $64.83 | $64.82 | -0.0% | +2.3% | +1.7% | +1.7% | +2.0% | +4.1% |
| Aug 6 | Evercore ISI | Maintains | In Line → In Line | — | $64.83 | $64.82 | -0.0% | +2.3% | +1.7% | +1.7% | +2.0% | +4.1% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $64.83 | $64.82 | -0.0% | +2.3% | +1.7% | +1.7% | +2.0% | +4.1% |
| Jul 25 | Stifel | Downgrade | Buy → Hold | — | $72.62 | $71.96 | -0.9% | -1.6% | -3.0% | -3.5% | -4.2% | -6.8% |
| Jul 14 | Baird | Downgrade | Outperform → Neutral | — | $73.42 | $70.38 | -4.1% | -3.7% | -3.8% | -5.6% | -5.3% | -5.9% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $73.95 | $74.54 | +0.8% | +0.3% | +0.8% | -0.7% | -4.4% | -4.5% |
| May 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $66.58 | $66.97 | +0.6% | -0.5% | -0.0% | +3.5% | +3.1% | +5.8% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $66.58 | $66.97 | +0.6% | -0.5% | -0.0% | +3.5% | +3.1% | +5.8% |
| Apr 30 | Piper Sandler | Maintains | Overweight → Overweight | — | $66.16 | $65.39 | -1.2% | -1.8% | -2.6% | -1.3% | +0.6% | +0.1% |
| Feb 26 | Barrington Research | Maintains | Outperform → Outperform | — | $75.82 | $75.88 | +0.1% | -4.3% | -4.9% | -4.8% | -6.6% | -7.3% |
| Feb 26 | UBS | Maintains | Neutral → Neutral | — | $75.82 | $75.88 | +0.1% | -4.3% | -4.9% | -4.8% | -6.6% | -7.3% |
| Jan 30 | Barrington Research | Maintains | Outperform → Outperform | — | $79.87 | $80.46 | +0.7% | +0.2% | +0.2% | -0.4% | +0.9% | +2.6% |
| Jan 23 | Jefferies | Maintains | Hold → Hold | — | $74.78 | $75.37 | +0.8% | -0.0% | +0.3% | +2.6% | +1.8% | +6.8% |
| Jan 6 | BofA Securities | Upgrade | Underperform → Buy | — | $69.09 | $71.59 | +3.6% | +3.9% | +3.7% | +2.9% | +0.8% | +2.3% |
| Nov 6 | Barrington Research | Maintains | Outperform → Outperform | — | $68.99 | $71.00 | +2.9% | +1.5% | +0.6% | -1.4% | -1.0% | -2.2% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $69.30 | $69.34 | +0.1% | +1.0% | +1.7% | +1.1% | +1.8% | +2.5% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $72.54 | $72.31 | -0.3% | -1.9% | -1.3% | -2.5% | -3.7% | -2.3% |
| Aug 12 | JP Morgan | Maintains | Overweight → Overweight | — | $68.94 | $68.40 | -0.8% | -1.5% | +0.7% | -0.6% | +1.2% | +1.2% |
| Aug 7 | Evercore ISI | Maintains | In Line → In Line | — | $63.92 | $64.81 | +1.4% | +2.9% | +6.6% | +7.9% | +6.2% | +8.6% |
| Aug 7 | UBS | Maintains | Neutral → Neutral | — | $63.92 | $64.81 | +1.4% | +2.9% | +6.6% | +7.9% | +6.2% | +8.6% |
| Aug 7 | Baird | Maintains | Outperform → Outperform | — | $63.92 | $64.81 | +1.4% | +2.9% | +6.6% | +7.9% | +6.2% | +8.6% |
| Aug 7 | Barrington Research | Maintains | Outperform → Outperform | — | $63.92 | $64.81 | +1.4% | +2.9% | +6.6% | +7.9% | +6.2% | +8.6% |
| Jul 22 | Baird | Upgrade | Neutral → Outperform | — | $70.34 | $71.61 | +1.8% | +0.9% | -0.5% | -0.1% | +1.0% | +2.8% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $64.75 | $64.54 | -0.3% | -0.5% | -0.9% | +0.5% | +0.6% | +1.7% |
| Jul 5 | Barrington Research | Maintains | Outperform → Outperform | — | $64.79 | $64.55 | -0.4% | +0.3% | -0.1% | -0.5% | -0.9% | +0.5% |
| Jun 21 | Piper Sandler | Maintains | Overweight → Overweight | — | $66.55 | $66.78 | +0.3% | +1.1% | +1.1% | -0.7% | -3.0% | -3.7% |
| May 8 | UBS | Maintains | Neutral → Neutral | — | $71.20 | $71.53 | +0.5% | +2.2% | +3.1% | +3.0% | +2.7% | +2.2% |
| May 8 | Barrington Research | Maintains | Outperform → Outperform | — | $71.20 | $71.53 | +0.5% | +2.2% | +3.1% | +3.0% | +2.7% | +2.2% |
| Mar 6 | Jefferies | Maintains | Hold → Hold | — | $75.41 | $75.78 | +0.5% | -0.1% | -0.3% | -0.9% | -0.5% | -1.3% |
No insider trades available.
8-K · 2.02
!! High
Henry Schein, Inc. -- 8-K 2.02: Earnings Results
Henry Schein reported Q1 2026 earnings results, providing investors with updated financial performance metrics to assess the company's operational health and trajectory.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure of an executive effective April 15, 2026 signals potential leadership uncertainty; investors should monitor whether the replacement demonstrates strategic continuity or signals broader organizational concerns affecting these companies' performance.
Apr 14
8-K
Henry Schein Inc -- 8-K Filing
Henry Schein reported Q4 2025 earnings growth with non-GAAP diluted EPS of $1.34 versus $1.19 year-over-year, while guiding 2026 EPS between $5.23-$5.37 with modest 3-5% sales growth.
Feb 24
Data updated apr 25, 2026 2:07pm
· Source: massive.com